Email this article 22 sentyabrya 2012 g. sostoyalsya press-brifing, posvyashchennyy roli targetnoy terapii v preodolenii lekarstvennoy rezistentnosti pri lechenii metastaticheskogo raka molochnoy zhelezy (mRMZh) i, v chastnosti, predstavleniyu obshchestvennosti novykh zaregistrirovannykh pokazaniy dlya primeneniya preparata Afinitor pri mRMZh
- Authors: - -
- Issue: Vol 14, No 3 (2012)
- Pages: 5-6
- Section: Articles
- URL: https://journals.rcsi.science/1815-1434/article/view/29480
- ID: 29480
Cite item
